Search Results 531-540 of 17717 for SC

  1. Publications - Pablo Moreno Franco, M.D. - Mayo Clinic

    ... SC, Pollock BD. Exploring COVID-19 census burdens by US hospital characteristics: Implications of quality reporting at rural and critical access hospitals ...

  2. A Study Of Lebrikizumab In Participants With Idiopathic Pulmonary Fibrosis - Mayo Clinic

    Participants will be randomized to receive either lebrikizumab or placebo subcutaneously (SC) every 4 weeks. Participation eligibility. Participant ...

  3. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    MTX: ≥15 mg/week subcutaneous (SC) or intramuscular (IM). Note: Oral MTX ... At least one 4-week induction regimen of adalimumab (one 160 mg SC dose at Week 0, ...

  4. Jaw surgery - Doctors & Departments - Mayo Clinic

    Bagheri SC, ed. Mandibular orthognathic surgery. In: Clinical Review of Oral and Maxillofacial Surgery. 3rd ed. Elsevier; 2025. https://www.clinicalkey.com ...

  5. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  6. Publications - Sonya Makhni, M.D., M.S. - Mayo Clinic

    Rojas JC, Fahrenbach J, Makhni S, Cook SC, Williams JS, Umscheid CA, Chin MH. Framework for Integrating Equity Into Machine Learning Models: A Case Study ...

  7. Publications - Kimberly A. Holst, M.D. - Mayo Clinic

    ... SC, Grayburn PA, Sannino A, Mack MJ, Leon MB, Lurz P, Kodali SK, TRISCEND II Trial Investigators. Transcatheter Valve Replacement in Severe Tricuspid ...

  8. A Study To Evaluate Effectiveness And Safety Of Ustekinumab Re-induction Therapy In Participants With Moderate To Severely Active Crohn's Disease (POWER) - Mayo Clinic

    ... (SC) every 8 Weeks (q8w) 90 mg ustekinumab maintenance therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  9. E. coli - Symptoms and causes - Mayo Clinic

    coli cause no harm or mild illness. But a few strains, such as E. coli O157:H7, can cause bad stomach cramps, bloody loose stools and vomiting, called diarrheal ...

  10. Colon Adenocarcinoma Clinical Trials - Mayo Clinic Research

    This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...